1. Home
  2. WNEB vs SENS Comparison

WNEB vs SENS Comparison

Compare WNEB & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

HOLD

Current Price

$13.26

Market Cap

264.8M

Sector

Finance

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$6.81

Market Cap

301.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNEB
SENS
Founded
1853
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Industrial Machinery/Components
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
264.8M
301.2M
IPO Year
2001
2014

Fundamental Metrics

Financial Performance
Metric
WNEB
SENS
Price
$13.26
$6.81
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$13.67
$18.38
AVG Volume (30 Days)
30.6K
1.2M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
2.00%
N/A
EPS Growth
33.93
N/A
EPS
0.24
N/A
Revenue
$44,000.00
$16,389,000.00
Revenue This Year
N/A
$74.15
Revenue Next Year
$7.25
$58.60
P/E Ratio
$55.46
N/A
Revenue Growth
N/A
19.85
52 Week Low
$8.53
$0.41
52 Week High
$14.52
$8.75

Technical Indicators

Market Signals
Indicator
WNEB
SENS
Relative Strength Index (RSI) 43.00 61.22
Support Level $13.06 $6.62
Resistance Level $13.42 $6.87
Average True Range (ATR) 0.37 0.42
MACD -0.03 0.17
Stochastic Oscillator 22.87 100.00

Price Performance

Historical Comparison
WNEB
SENS

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: